Cable Hill Partners, LLC Nektar Therapeutics Transaction History

Cable Hill Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$30.43 - $56.65 $6,086 - $11,330	-200 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $40,466 - $59,654	-871 Reduced 81.33%	200 $10,000
Q2 2018 Aug 03, 2018	BUY	$46.25 - $104.45 $46,250 - $104,450	1,000 Added 1408.45%	1,071 $52,000
Q1 2018 Apr 20, 2018	SELL	$57.4 - $108.44 $6,773 - $12,795	-118 Reduced 62.43%	71 $7,000
Q4 2017 Feb 22, 2018	BUY	$23.02 - $60.5 $4,350 - $11,434	189	189 $11,000

126

109M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $259M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.